PharmiWeb.com - Global Pharma News & Resources
09-Jul-2019

DNA and Gene Chip Market Size Poised to Touch USD 11.4 Billion by 2026

The Global DNA and Gene Chip Market Size is expected to reach USD 11.4 Billion by 2026 and growing CAGR around 10.5% during the forecast period from 2018 to 2026.

DNA and gene chips have increased much achievement in giving high throughput abilities to thorough genome concentrates to upgrade malady information and target them. This innovation has risen as an important and promising arrangement crosswise over different parts of illness the executives. These variables have been driving the market.

Traditional methods for gene examination permit examination of generally little measures of qualities at once, which further accentuates on the take-up of DNA microarray innovation. DNA microarray innovation permits simultaneous examination of huge quantities of nucleic corrosive sections in a solitary trial.

Constant improvement of new apparatuses to help and upgrade dependability of DNA microarray innovation is probably going to drive this market at a noteworthy pace within a reasonable time-frame. Moreover, social insurance elements are occupied with misusing novel answers for improving and joining information created from gene chip with information produced from high throughput innovations. Commonly gainful associations between microarray engineers and pharmaceutical/biopharmaceutical organizations for speeding up of genomic and biomedical research exercises is foreseen to goad showcase development in the coming years.

Research joint efforts among organizations and research networks is helping the innovation in picking up grounds in the field of genomics. For example, in February 2016, Illumina, Inc. consented to four biobanking arrangements with University of Colorado, Montreal Heart Institute, Vanderbilt University, and Partners HealthCare. This joint effort was expected for the execution of Illumina's cluster stage for genotyping of test gathered at research establishments.

Download Free Sample Pages at https://www.acumenresearchandconsulting.com/request-sample/1015

The global DNA and gene chip market is segmented into product, end-user, application, and region. On the basis of product, the global DNA and gene chip market is segmented into Consumables and Instrumentation. On the basis of end-user, the global DNA and gene chip market is segmented into Academic amp; Government Research Institutes, Hospitals amp; Diagnostics Centers, Biotechnology amp; Pharmaceutical Companies and Others. On the basis of application, the global DNA and gene chip market is segmented into cancer diagnosis amp; treatment, gene expression, genotyping, genomics, drug discovery, agricultural biotechnology, and others. On the basis of region the global DNA and gene chip market is bifurcated into Europe, Latin America, North America, Middle East amp; Africa, and Asia Pacific.

The capacity of gene chips in high-throughput observing of bimolecular has activated critical applications in new regions of intrigue, for example, pharmacogenomics. This factor has incited a few pharmaceutical firms to embrace this instrument for increasing speed of medication advancement process.

Viable usage of genomic chips for gene articulation examination has additionally empowered the utilization of this apparatus in non-customary research regions, for example, natural science and agribusiness. Agri-biotech organizations and research establishments are making noteworthy utilization of microarray innovation for testing of hereditarily altered sustenancersquo;s and yield enhancement to conquer difficulties of product reproducibility. Although, this innovation is encountering high market rivalry from other throughput advancements, for example, cutting edge sequencing. Falling expenses of sequencing advances attributable to fast advances in NGS is required to significantly obstruct the future market for DNA gene chips. Applications, for example, chromatin immune precipitation and gene articulation are seeing higher appropriation of NGS stages over microarrays because of its cost-viability, particularity, and precision.

The North America showcase caught the largest market share, for example, nearness of entrenched players, propelled informatics framework, nearness of specialists and gifted workforce, and continuous genomic R and D rehearses on a vast scale in the district.

Asia Pacific is relied upon to rise as a promising business sector, enlisting the most noteworthy CAGR over the conjecture time frame because of rising research and development demand in genomic examine. Besides, developing mindfulness with respect to hereditary tests for malady hazard evaluation and aversion is foreseen to positively affect the development of the regional market

The key players catering to the global DNA and Gene Chip Market are bio Meacute;rieuxSA, Thermo Fisher Scientific, Inc. (Affymetrix, Inc.),Savyon Diagnostics, Agilent Technologies, Applied Micro Arrays, Illumina, Inc., HOKUTO ELECTRONICS CORPORATION, TOSHIBA, Perkin Elmer, Inc., Oxford Gene Technology,Arrayit Corporation,MYcroarray,Macrogen Inc., Greiner Bio One International GmbH, Asper Biotech, CapitalBio Corporation, and Microarrays Inc.

View Detail Information With Complete TOC at https://www.acumenresearchandconsulting.com/dna-and-gene-chip-market

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of DNA and Gene Chip
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. DNA and Gene Chip Market By Application
1.2.2.1. Global DNA and Gene Chip Market Revenue and Growth Rate Comparison By Application (2015-2026)
1.2.2.2. Global DNA and Gene Chip Market Revenue Share By Application in 2017
1.2.2.3. Cancer Diagnosis amp; Treatment
1.2.2.4. Gene Expression
1.2.2.5. Genotyping
1.2.2.6. Genomics
1.2.2.7. Drug Discovery
1.2.2.8. Agricultural Biotechnology
1.2.2.9. Others
1.2.3. DNA and Gene Chip Market By Product
1.2.3.1. Global DNA and Gene Chip Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.3.2. Consumables
1.2.3.3. Instrumentation
1.2.3.4. Others
1.2.4. DNA and Gene Chip Market By End Users
1.2.4.1. Global DNA and Gene Chip Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Academic amp; Government Research Institutes
1.2.4.3. Hospitals amp; Diagnostics Centers
1.2.4.4. Biotechnology amp; Pharmaceutical Companies
1.2.4.5. Others
1.2.5. DNA and Gene Chip Market by Geography
1.2.5.1. Global DNA and Gene Chip Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America DNA and Gene Chip Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe DNA and Gene Chip Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific DNA and Gene Chip Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America DNA and Gene Chip Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) DNA and Gene Chip Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global DNA and Gene Chip Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global DNA and Gene Chip Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global DNA and Gene Chip Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global DNA and Gene Chip Major Manufacturers in 2017

CHAPTER 4. DNA AND GENE CHIP MARKET BY APPLICATION

4.1. Global DNA and Gene Chip Revenue By Application
4.2. Cancer Diagnosis amp; Treatment
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Gene Expression
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Genotyping
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Genomics
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. Drug Discovery
4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.7. Agricultural Biotechnology
4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.8. Other
4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. DNA AND GENE CHIP MARKET BY PRODUCT

5.1. Global DNA and Gene Chip Revenue By Product
5.2. Consumables
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Instrumentation
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. DNA AND GENE CHIP MARKET BY END USERS

6.1. Global DNA and Gene Chip Revenue By End Users
6.2. Academic amp; Government Research Institutes
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Hospitals amp; Diagnostics Centers
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Biotechnology amp; Pharmaceutical Companies
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others
6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA DNA AND GENE CHIP MARKET BY COUNTRY

7.1. North America DNA and Gene Chip Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America DNA and Gene Chip Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. U.S.
7.3.1. U.S. DNA and Gene Chip Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE DNA AND GENE CHIP MARKET BY COUNTRY

8.1. Europe DNA and Gene Chip Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe DNA and Gene Chip Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC DNA AND GENE CHIP MARKET BY COUNTRY

9.1. Asia-Pacific DNA and Gene Chip Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific DNA and Gene Chip Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA DNA AND GENE CHIP MARKET BY COUNTRY

10.1. Latin America DNA and Gene Chip Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America DNA and Gene Chip Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST DNA AND GENE CHIP MARKET BY COUNTRY

11.1. Middle East DNA and Gene Chip Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East DNA and Gene Chip Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. AFRICA DNA AND GENE CHIP MARKET BY COUNTRY

12.1. Africa DNA and Gene Chip Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa DNA and Gene Chip Market Revenue Share Comparison, 2015 amp; 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. DNA and gene chip Meacute;rieux SA
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. Thermo Fisher Scientific, Inc. (Affymetrix, Inc.)
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Savyon Diagnostics
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Agilent Technologies
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Applied Micro Arrays
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Illumina, Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. HOKUTO ELECTRONICS CORPORATION
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. TOSHIBA, Perkin Elmer, Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Oxford Gene Technology
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Arrayit Corporation
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. MYcroarray
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies
13.12. Macrogen Inc
13.12.1. Company Snapshot
13.12.2. Overview
13.12.3. Financial Overview
13.12.4. Type Portfolio
13.12.5. Key Developments
13.12.6. Strategies
13.13. Greiner Bio One International GmbH
13.13.1. Company Snapshot
13.13.2. Overview
13.13.3. Financial Overview
13.13.4. Type Portfolio
13.13.5. Key Developments
13.13.6. Strategies
13.14. Asper Biotech
13.14.1. Company Snapshot
13.14.2. Overview
13.14.3. Financial Overview
13.14.4. Type Portfolio
13.14.5. Key Developments
13.14.6. Strategies
13.15. CapitalBio Corporation
13.15.1. Company Snapshot
13.15.2. Overview
13.15.3. Financial Overview
13.15.4. Type Portfolio
13.15.5. Key Developments
13.15.6. Strategies
13.16. Microarrays Inc.
13.16.1. Company Snapshot
13.16.2. Overview
13.16.3. Financial Overview
13.16.4. Type Portfolio
13.16.5. Key Developments
13.16.6. Strategies
13.17. Others
13.17.1. Company Snapshot
13.17.2. Overview
13.17.3. Financial Overview
13.17.4. Type Portfolio
13.17.5. Key Developments
13.17.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING at https://www.acumenresearchandconsulting.com/inquiry-before-buying/1015

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1015

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 09-Jul-2019